1: Noronha-Blob L, Sturm BL, Lowe VC, Jackson KN, Kachur JF. In vitro and in vivo antimuscarinic effects of (-)cis 2,3-dihydro-3-(4-methylpiperazinylmethyl)-2-phenyl-1,5 benzothiazepin-4-(5H)one HCl (BTM-1086) in guinea pig peripheral tissues. Life Sci. 1990;46(17):1223-31. PubMed PMID: 2338887.
2: Takayanagi I, Nakazo K, Kizawa Y. Possible mechanisms of a new type of antispasmodic drug, BTM-1042(cis-(--)-2,3-dihydro-3-(4-methyl-piperazinyl)methyl-2-phenyl-1,5-benzoth iazepin-4(5H)-one dihydrochloride). Jpn J Pharmacol. 1980 Oct;30(5):647-54. PubMed PMID: 7206371.
3: Yamamoto H, Nakamura Y, Nagasaka M, Asai H. Specificity in the pharmacological actions of optical isomers of cis-2,3-dihydro-3-(4-methylpiperazinylmethyl)-2-phenyl-1,5- benzothiazepin-4(5H)-one (BTM). Chem Pharm Bull (Tokyo). 1987 Aug;35(8):3419-24. PubMed PMID: 3427721.
4: Asano T, Okumura T, Hirano K, Adachi T, Sugiura M. Competitive enzyme immunoassay for anti-ulcer agent, (-)-cis-2,3-dihydro-3-(4-methylpiperazinylmethyl)-2-phenyl-1,5- benzothiazepin-4(5H)-one hydrochloride (BTM-1086). Chem Pharm Bull (Tokyo). 1986 Oct;34(10):4238-43. PubMed PMID: 3549012.
5: Ohno S, Izumi K, Mizukoshi K, Kato K, Hori M. Synthesis of a new potent anti-ulcer and gastric secretory inhibiting agent, (-)-cis-2,3-dihydro-3-(4-methylpiperazinylmethyl)-2-phenyl-1,5-benzothiazepin-4(5 H)-one hydrochloride (BTM-1086), and related compounds. Chem Pharm Bull (Tokyo). 1983 May;31(5):1780-3. PubMed PMID: 6616728.
6: Yamamoto H, Asai H. Effects of (-)-cis-2,3-dihydro-3-(4-methylpiperazinylmethyl)-2-phenyl- 1,5-benzothiaze pin-4-(5H)-one hydrochloride (BTM-1086) on ulceration, gastric secretion and mucosal blood flow in experimental animals. Chem Pharm Bull (Tokyo). 1986 Sep;34(9):3844-53. PubMed PMID: 3815606.
7: Eltze M, Boer R, Mutschler E, Lambrecht G. Affinity profiles of BTM-1086 and BTM-1041 at muscarinic receptor subtypes and at H1- and alpha 1-receptors. Eur J Pharmacol. 1989 Nov 7;170(3):225-34. PubMed PMID: 2575995.
8: Yamamoto H, Nakamura Y, Kunoh Y, Ichihara K, Nagasaka M, Asai H. Antiulcer effect of (-)-cis-2,3-dihydro-3-(4-methylpiperazinylmethyl) -2-phenyl-1,5-benzothiazepin-4-(5H)-one hydrochloride (BTM-1086) in experimental animals. Jpn J Pharmacol. 1986 Jul;41(3):283-92. PubMed PMID: 3761747.
9: Takayanagi I, Konno F, Akaike M, Nibori Y, Yamura S. cis(-)-2,3-Dihydro-3-(4-methylpiperazinylmethyl)-2-phenyl-1,5- benzothiazepin-4(5H)-one monohydrochloride and its butylbromide as M1-receptor antagonists. Gen Pharmacol. 1987;18(1):91-3. PubMed PMID: 3557056.
10: Murakami H, Ishikawa T, Watanabe H. Acetylcholine release elicited by electrical stimulation and its sites of action in smooth muscle of Mytilus. Comp Biochem Physiol C. 1984;77(2):273-7. PubMed PMID: 6144427.
11: Kromer W, Baron E, Boer R, Eltze M. Telenzepine inhibits electrically-stimulated, acetylcholine plus histamine-mediated acid secretion in the mouse isolated stomach by blockade of M1 muscarine receptors. Naunyn Schmiedebergs Arch Pharmacol. 1991 Jan;343(1):7-13. PubMed PMID: 2030745.
12: Okumura T, Asano T, Adachi T, Hirano K. Enzyme immunoassay for the drug of anti-ulcer using avidin-biotin system. Chem Pharm Bull (Tokyo). 1991 Jul;39(7):1779-81. PubMed PMID: 1777930.